|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANIMAL PRODUCTION |


* USDA, ARS, US Sheep Experiment Station, Dubois, ID 83423; and
USDA, ARS, Animal Disease Research Unit, Pullman, WA 99164
| Abstract |
|---|
|
|
|---|
Key Words: methodology sheep vaccination
| INTRODUCTION |
|---|
|
|
|---|
Pneumatically powered, needle-free injection devices are an alternative to needle injection. Needle-free systems use pressurized gas to drive vaccine through skin and into the subcutis or muscle (Vyrzhikovskaya and Bandakov, 1967
; Jackson et al., 2001
). Since the 1940s, these devices have been used to vaccinate humans (Hingson et al., 1963
; Sarno et al., 2000
). Immune responses are similar, and in some cases greater, when vaccines are injected with a needle-free device, compared with needles, in humans (Parent du Chatelet et al., 1997
; Williams et al., 2000
), swine (Houser et al., 2004
; Jones et al., 2005
), and cattle (Hollis et al., 2005
).
Alternatives to needle vaccinations have been unavailable to sheep producers because pneumatic, needle-free injectors were not designed to cope with the fleece. Pneumatic, needle-free injectors on the market for livestock, primarily cattle and swine, are triggered to inject by mechanical pressure on the nozzle as it touches skin, and are not hindered by thin coats of hair. In sheep, premature injections can occur when attempting to penetrate wool, thus resulting in unsuccessful delivery of the vaccine. Vaccines could be delivered via pneumatic, needle-free injection after shearing, but this may not fit with a producers management plan.
The objective of this study was to evaluate a pneumatically powered, needle-free injector, modified for sheep, for vaccine delivery, throughput, and immune response, in comparison with traditional needle injections.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Injection Systems
Needle-free. A prototype Pulse250 was purchased from Pulse NeedleFree Systems (Lenexa, KS). The hand piece was modified such that the pressure required to mechanically trigger an injection was increased (the modification was done by Pulse NeedleFree Systems and is proprietary information) to enable wool penetration and skin contact before injection. The Pulse250 is a mobile unit capable of administering 0.5-to 2.5-mL doses in 0.5-mL increments and is pneumatically powered with gaseous CO2 from the head space above the liquid CO2 stored in a 0.7-L tank.
Needle. A Roux, pistol-grip, 50-mL syringe was purchased from Valley Vet (Marysville, KS). This model can administer 1- to 5-mL doses, in 1-mL increments, and was capable of needle changes between animals.
Injection Pressure
To determine the pneumatic pressure required to penetrate the skin and inject vaccines s.c. with the pneumatic, needle-free injector, two 8-mo-old wether lambs were anesthetized to a surgical plane with 16 mg/kg of pentobarbital sodium. Once anesthetized, the animals were injected in the neck through approximately 3.8 cm of wool, twice for each injection pressure evaluated. Pressure was increased with each 2-mL injection of Chinese ink (0.5 mL of ink diluted to 45 mL with sterile, isotonic saline; Sigma-Aldrich, St. Louis, MO), from 207 to 414 kPa in increments of 69 kPa. The lambs were also injected with a needle to compare the injection depth to that of the pneumatic, needle-free injections. After injection of the dye, the lambs were killed with 80 mg/kg of pentobarbital sodium. The injection sites were sheared and dissected to determine whether the injection penetrated the skin, was s.c., or was i.m.
Animals, Inoculation, and Sample Collection
Wether lambs (Rambouillet, Polypay, and Targhee) at 8 mo of age were used. Lambs were born in March and April, herded on sagebrush steppe (May to late June), subalpine range (late June to September), and sagebrush steppe (September to November), and then maintained together in a feedlot on a diet that met the NRC (1985)
maintenance requirements from November to the end of the study in January 2007.
Before inoculation, 4 treatments, in a 2 x 2 factorial array, were randomly assigned to 100 wethers. Treatments were s.c. injection in the neck, with either the pneumatic, needle-free injector or a needle, of 6 mg of ovalbumin (Sigma-Aldrich, >90% pure) dissolved in 1 mL of sterile, isotonic saline and 1 mL of an aluminum hydroxide adjuvant (Alhydrogel, Accurate Chemical and Scientific Corp., Westbury, NY), or of 2 mL of a commercial vaccine, containing an aluminum hydroxide adjuvant, for a common sheep disease. Therefore, each lamb received a needle injection and a pneumatic, needle-free injection, with different antigens, on opposite sides of the neck. During inoculation, the lambs were sorted by injection type and antigen to minimize the frequency of cleaning and the switching of antigens in the injection systems. Primary inoculations were given on d 0 and secondary inoculations were given on d 28 of the experiment. Blood samples were collected via jugular venipuncture into uncoated vacuum tubes (Becton Dickinson, San Jose, CA) on d 0, 14, 28, and 42. Serum was collected within 2 h after blood collection and stored at –20°C until tested for antibodies.
Time Comparison
Injection time, time to change the needles between animals, and time to fill the needle injection system, or inject with the pneumatic, needle-free injector were recorded during administration of the secondary inoculation. The needle injection system was refilled 3 times. The time to replace bottles (2 total) for the pneumatic, needle-free injector (generally less than 10 s) was not recorded because, typically, large-volume vaccine bottles would be used and would not need to be changed when vaccinating only 100 sheep. Because each lamb received a needle and a pneumatic, needle-free injection, the time to inject 7 to 9 sheep (as many as would fit in the chute) was replicated 14 times (all 100 wethers timed) for each injection type.
Antibody Response
A commercial, synergistic, hemolytic inhibition test was used to test for antibodies to the commercial vaccine. Serum antibody titers to ovalbumin were determined using an ELISA, similar to the one described in Sevi et al. (2002)
. Ovalbumin, at 1 µg per well, was applied to each well, allowed to adhere overnight, washed with PBS (Sigma-Aldrich), the blocking buffer was applied for 1 h, and then serum was applied. Serum was titrated to 7 dilutions, the concentration dependent on what day the samples were collected, and assayed in triplicate. We deviated from the procedure of Sevi et al. (2002)
so that 96-well, flat-bottomed micro-titer plates (Nalge Nunc International, Rochester, NY) were incubated with BSA in PBS (blocking buffer; Sigma-Aldrich) for 1 h to reduce nonspecific binding, and the plates were allowed to develop color (darker color indicating a greater antibody concentration) for 25 min, and then the reaction was stopped with 1 N hydrochloric acid (Sigma-Aldrich). Positive controls were pooled from 20 serum samples collected on d 42 and assayed undiluted on each plate in quadruplicate. The inter- and intraassay CV were 6.0 and 4.6%, respectively, for the positive controls.
Statistical Analysis
To determine whether time differed with injection method, a paired-difference t-test was conducted using SAS (SAS Inst. Inc., Cary, NC). Serum dilutions (optical density, OD) had the background OD (without serum) subtracted and then were averaged for each dilution. An OD reading of less than 0.01 was considered negative for ovalbumin antibodies. Therefore, the adjacent dilution in the series, with an OD reading greater than 0.01, was considered the antibody titer. A logistic regression, proportional odds model (using PROC LOGISTIC of SAS) was used to test if the antibody titers were different for injection type, using a full model containing day of serum collection, breed, and injection type.
| RESULTS |
|---|
|
|
|---|
|
The commercial synergistic hemolytic inhibition test did not detect antibodies to the commercial vaccine at d 14, 28, or 42, regardless of injection method. Thus, there were no antibody data from the commercial vaccine to analyze.
Antibody titers for ovalbumin for each week of serum collection and injection type are displayed in Figure 2
. For d 0, nonspecific binding was detected for all sheep, with pneumatic, needle-free injected animals showing a titer of 1:1,000 and needle injected a titer of 1:500. After primary and secondary vaccination, antibody titers were not different (P > 0.12) regardless of injection method for d 14, 28, and 42. As expected, antibody titers were increased on d 14 and 42 after primary and secondary inoculations, respectively.
|
| DISCUSSION |
|---|
|
|
|---|
Modification of the pneumatic, needle-free injector to increase mechanical trigger pressure allowed for wool (approximately 3.8 to 5.1 cm staple length) penetration and skin contact before injection. Optimal injection pressure was found to be between 207 and 276 kPa for s.c. injections in 8-mo-old lambs, which is similar to that required for s.c. injection in swine with the Pulse250 (Pulse NeedleFree Systems).
One advantage of this technology over conventional needle vaccinations is speed of delivery (Giudice and Campbell, 2006
). In this study, time to inject 100 sheep with the pneumatic, needle-free injector was 60% less than the time for needle injections when needles were changed between animals. At the US Sheep Experiment Station, we administer about 9,800 vaccinations per year. Thus we are able to administer about 5,970 more vaccinations in a specific timeframe with the pneumatic, needle-free injector than is possible when changing needles between animals. This represents a considerable time and labor savings. Additional advantages of the pneumatic, needle-free injector include elimination of the occupational hazard of accidental needle sticks and reduction of biohazard waste produced from discarded used or damaged needles. During this study, sheep appeared to be less stressed (less jumping, shying, vocalizing) when inoculated with the pneumatic, needle-free injector than when injected with a needle.
The results of this study indicate that a modified pneumatic, needle-free injector can be effective in administering antigens to sheep. We expect vaccines injected with the pneumatic, needle-free injector to produce similar or greater antibody responses as needle injections in sheep, as was demonstrated in swine (Houser et al., 2004
) and cattle (Hollis et al., 2005
); however, further studies are needed with sheep to evaluate this system with commercial vaccines.
| Footnotes |
|---|
2 The authors wish to acknowledge T. Kellom, M. Williams, T. Northcutt, J. B. Taylor, and the US Sheep Experiment Station operations staff for animal handling, data collection, and laboratory procedures. ![]()
3 Corresponding author: Michelle.Mousel{at}ars.usda.gov
Received for publication December 31, 2007. Accepted for publication February 20, 2008.
| LITERATURE CITED |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |